Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design Evaluation.
Farhana KhanamMd Taufiqul IslamFaisal AhmmedShams Uddin AhmedMd Ismail HossenMdNazmul Hasan RajibShahinur HaquePrasanta Kumar BiswasImam TauheedK ZamanAhmed Nawsher AlamMallick Masum Billahnull MonalisaShah Ali Akbar AshrafiMohammed Ziaur RahmanOmar Hamza Bin ManjurMokibul Hassan AfradS M ShamsuzzamanAhmed Abu SalehMostafa Aziz SumonAsif RashedMd Taufiqur Rahman BhuiyanFahima ChowdhuryAshraful Islam KhanMeerjady Sabrina FloraTahmina ShirinJohn D ClemensFirdausi QadriPublished in: Vaccines (2022)
Vaccine protection against COVID-19 disease of any severity caused by the Delta variant was modest in magnitude and significant for only one of the three evaluable vaccines. In contrast, protection against severe disease was high in magnitude and consistent for all three vaccines. Because our findings are not in complete accord with evaluations of the same vaccines in more affluent settings, our study underscores the need for country-level COVID-19 vaccine evaluations in developing countries.